Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NPIPA7 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | YTHDF2 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | HIST2H4A | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | NNMT | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | GPR39 | CTRPv2 | pan-cancer | AAC | -0.15 | 6e-05 |
mRNA | LYSMD3 | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
mRNA | FKBP6 | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
mRNA | MTR | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | ZSCAN2 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |
mRNA | KIAA0895 | CTRPv2 | pan-cancer | AAC | 0.14 | 6e-05 |